Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Zogenix names new board member

This article was originally published in Scrip

Executive Summary

San Diego-based Zogenix, a pharmaceutical company developing products for the treatment of pain-related conditions and central nervous system disorders, has named Dr James B Breitmeyer to its board of directors. Dr Breitmeyer currently serves as president of Bavarian Nordic, a late-stage biotechnology company. He is also executive vice-president of Bavarian A/S, a multinational corporation headquartered in Denmark which specializes in the research, development and manufacturing of vaccines and immunotherapy regimens for biodefense, infectious diseases and oncology. He has also previously served as acting chief medical officer of Zogenix in an advisory capacity.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts